share_log
Reuters ·  Sep 23 09:32
Biohaven Shares Jump 12.6% After Co's Genetic Disease Drug Meets Main Trial Goal
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment